Basel: A Hotspot for Drug Discovery and Development Against Poverty-related Diseases

被引：2

作者：

Meier, Lukas ^{[1
,2
]}

机构：

[1] Swiss Trop & Publ Hlth Inst, CH-4123 Allschwil, Switzerland

[2] Univ Basel, CH-4001 Basel, Switzerland

来源：

CHIMIA | 2023年 / 77卷 / 09期

关键词：

Drugs; Leprosy; Malaria; Neglected tropical diseases; Novartis; Product development partnerships; Public-private partnerships; Research & development; Swiss Tropical and Public Health Institute;

D O I：

10.2533/chimia.2023.613

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

In discussion with Lukas Meier from the Swiss Tropical and Public Health Institute (Swiss TPH), Lutz Hegemann, Head of Novartis Global Health and Sustainability and Marcel Tanner, President of the Swiss Academies of Arts and Sciences, give their opinions on the changes that occurred in drug discovery and development for poverty-related diseases over the past 30 years. They emphasise the power of public-private partnerships and provide their points of views on what needs to be done in the future to ensure that the poorest of the poor also have access to important therapies.

引用

页码：613 / 615

页数：3

共 12 条

[1] Poverty-related and neglected diseases - an economic and epidemiological analysis of poverty relatedness and neglect in research and development
von Philipsborn, Peter
Steinbeis, Fridolin
Bender, Max E.
Regmi, Sadie
Tinnemann, Peter
GLOBAL HEALTH ACTION, 2015, 8
[2] Poverty-related diseases (PRDs): Unravelling complexities in disease responses in Cameroon
Makoge V.
Maat H.
Vaandrager L.
Koelen M.
Tropical Medicine and Health, 45 (1)
[3] Neglected tropical diseases: an effective global response to local poverty-related disease priorities
Engels, Dirk
Zhou, Xiao-Nong
INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
[4] Neglected tropical diseases: an effective global response to local poverty-related disease priorities
Engels Dirk
Zhou XiaoNong
贫困所致传染病（英文）, 2020, 09 (01) : 9 - 17
[5] Neglected tropical diseases: an effective global response to local poverty-related disease priorities
Dirk Engels
Xiao-Nong Zhou
Infectious Diseases of Poverty, 9
[6] Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects
Radosevic, Katarina
Rodriguez, Ariane
Lemckert, Angelique
Goudsmit, Jaap
EXPERT REVIEW OF VACCINES, 2009, 8 (05) : 577 - 592
[7] Drug discovery and development for neglected diseases: the DNDi model
Chatelain, Eric
Ioset, Jean-Robert
DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 175 - 181
[8] Computational approaches for drug discovery against trypanosomatid-caused diseases
Pereira, Claudio A.
Saye, Melisa
Reigada, Chantal
Silber, Ariel M.
Labadie, Guillermo R.
Miranda, Mariana R.
Valera-Vera, Edward
PARASITOLOGY, 2020, 147 (06) : 611 - 633
[9] Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases
Mustiere, Romain
Dassonville-Klimpt, Alexandra
Sonnet, Pascal
FUTURE MEDICINAL CHEMISTRY, 2024, 16 (13) : 1357 - 1373
[10] Isoprenoid Precursor Biosynthesis Offers Potential Targets for Drug Discovery Against Diseases Caused by Apicomplexan Parasites
Hunter, William N.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (16) : 2048 - 2059

← 1 2 →